TSX:PLC - Post Discussion
Post by
retiredcf on Aug 09, 2022 9:04am
RBC
Their upside scenario target is $66.00. GLTA
Outperform
TSX: PLC; CAD 31.90
Price Target CAD 50.00 ↓ 54.00
Park Lawn Corporation
Watering the lawn: Reiterating constructive view ahead of Q2
Our view: Forecasting EBITDA $21.8MM (+17% Y/Y), slightly above consensus $21.0MM (range $19.0-$22.4MM) when PLC reports Q2 on August 11. While Q-to-Q visibility is muddled by the ebb and flow of regional death rates and cadence of M&A, we reiterate our favourable long-term view and recommend investors benchmark valuation against broader attributes, namely: i) defensive, relatively inelastic demand, ii) demonstrated resilience through downturns, iii) demographic tailwind, and iv) industry fragmentation with succession challenges. Reiterating OP rating, PT to $50 (-$4) on multiple tweak.
Key points:
Tweaking Q2 estimates, long-term outlook unchanged and predicated on acceleration of M&A in H2. Assumptions underlying our Q2E include -2% SSS normalizing from +13.1% prior year and reflecting lower volume partly offset by higher revenue per call and pricing. Modest EBITDA margin pressure ~30 bps Y/Y to 25.5% reflects high fixed cost nature of the business.
-
Forecasts reflect the Farris and Shackelford acquisitions (~US$4.6 MM annual EBITDA) scheduled to close in Q3, and the opening of Westminster Funeral, Visitation and Reception Centre in Toronto that could provide a bump to SSS reflecting previously contracted revenue stream.
-
Our forecasts incorporate M&A of US$105-$110 MM in 2022, moderating thereafter to average US$65-75 MM to deliver just over US $150 MM EBITDA in 2026. Assuming PLC can continue to do M&A at the targeted average of 6-8x LTM EBITDA on larger transactions, there is arguably upside to forecasts if cadence is closer to mid-point or upper end of the range. Efficiencies from FaCTS proprietary software could drive modest upward bias to profitability and eventually a new revenue vector if deployed to third parties
Rolling valuation basis forward to Q2/F24 (June 2024) to reflect the passage of time, moderating target multiple from 14.5x to 13.5x EBITDA to reflect the impact of higher long-term rates on valuations, price target to $50 (-$4). Target multiple revision implies 10% discount rate on 2031 valuation, up 50bps. Stock currently trading at ~17.5X NTM consensus EPS, almost two standard deviations below the five-year average (Ex. 4), and at the low-end of the range relative to SCI, staples and discretionary indices (Ex. 5). In our view, moderating valuation reflects: i) flow of funds against the backdrop of rising rates, inflation and related impact on consumer spending, ii) recent pace of M&A, and iii) muddled visibility as death rates normalize. More substantive M&A announcements could be a key catalysts for valuation re-rating, in our view. PLC-hosted investor day and site tour on September 29 could be a catalyst for the stock. PLC is included on the RBC CM Small Cap Conviction List.
Be the first to comment on this post